These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29800498)

  • 1. Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity.
    Cai Y; Makarova AM; Wengel J; Howard KA
    J Gene Med; 2018 Jul; 20(7-8):e3025. PubMed ID: 29800498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation.
    Hvam ML; Cai Y; Dagnæs-Hansen F; Nielsen JS; Wengel J; Kjems J; Howard KA
    Mol Ther; 2017 Jul; 25(7):1710-1717. PubMed ID: 28641935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics.
    Cai Y; Lou C; Wengel J; Howard KA
    Methods Mol Biol; 2020; 2176():163-174. PubMed ID: 32865790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus.
    Okamoto S; Echigoya Y; Tago A; Segawa T; Sato Y; Itou T
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hyaluronic acid-based hydrogel enabling CD44-mediated chondrocyte binding and gapmer oligonucleotide release for modulation of gene expression in osteoarthritis.
    Cai Y; López-Ruiz E; Wengel J; Creemers LB; Howard KA
    J Control Release; 2017 May; 253():153-159. PubMed ID: 28274742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.
    Kasuya T; Hori S; Watanabe A; Nakajima M; Gahara Y; Rokushima M; Yanagimoto T; Kugimiya A
    Sci Rep; 2016 Jul; 6():30377. PubMed ID: 27461380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice.
    Kakiuchi-Kiyota S; Koza-Taylor PH; Mantena SR; Nelms LF; Enayetallah AE; Hollingshead BD; Burdick AD; Reed LA; Warneke JA; Whiteley LO; Ryan AM; Mathialagan N
    Toxicol Sci; 2014 Mar; 138(1):234-48. PubMed ID: 24336348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of gapmer antisense oligonucleotide with deoxyribonucleic guanidine (DNG) modifications.
    Kojima N; Shrestha AR; Akisawa T; Piao H; Kizawa H; Ohmiya Y; Kurita R
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):258-269. PubMed ID: 31556356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.
    Grünweller A; Wyszko E; Bieber B; Jahnel R; Erdmann VA; Kurreck J
    Nucleic Acids Res; 2003 Jun; 31(12):3185-93. PubMed ID: 12799446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells.
    Castanotto D; Lin M; Kowolik C; Wang L; Ren XQ; Soifer HS; Koch T; Hansen BR; Oerum H; Armstrong B; Wang Z; Bauer P; Rossi J; Stein CA
    Nucleic Acids Res; 2015 Oct; 43(19):9350-61. PubMed ID: 26433227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense Gapmers with LNA-Wings and (
    Zhou Y; Sakamoto S; Ueno Y
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.
    Fluiter K; Mook OR; Vreijling J; Langkjaer N; Højland T; Wengel J; Baas F
    Mol Biosyst; 2009 Aug; 5(8):838-43. PubMed ID: 19603119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-tuning of ENA gapmers as antisense oligonucleotides for sequence-specific inhibition.
    Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
    Oligonucleotides; 2007; 17(3):291-301. PubMed ID: 17854269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.
    Beck GF; Irwin WJ; Nicklin PL; Akhtar S
    Pharm Res; 1996 Jul; 13(7):1028-37. PubMed ID: 8842040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.
    Kang H; Fisher MH; Xu D; Miyamoto YJ; Marchand A; Van Aerschot A; Herdewijn P; Juliano RL
    Nucleic Acids Res; 2004; 32(14):4411-9. PubMed ID: 15316104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin-hyaluronic acid hydrogel-based delivery of antisense oligonucleotides for ADAMTS5 inhibition in co-delivered and resident joint cells in osteoarthritis.
    Garcia JP; Stein J; Cai Y; Riemers F; Wexselblatt E; Wengel J; Tryfonidou M; Yayon A; Howard KA; Creemers LB
    J Control Release; 2019 Jan; 294():247-258. PubMed ID: 30572032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells.
    Kupryushkin MS; Filatov AV; Mironova NL; Patutina OA; Chernikov IV; Chernolovskaya EL; Zenkova MA; Pyshnyi DV; Stetsenko DA; Altman S; Vlassov VV
    Mol Ther Nucleic Acids; 2022 Mar; 27():211-226. PubMed ID: 34976439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gapmer Antisense Oligonucleotides Containing 2',3'-Dideoxy-2'-fluoro-3'-C-hydroxymethyl-β-d-lyxofuranosyl Nucleotides Display Site-Specific RNase H Cleavage and Induce Gene Silencing.
    Danielsen MB; Lou C; Lisowiec-Wachnicka J; Pasternak A; Jørgensen PT; Wengel J
    Chemistry; 2020 Jan; 26(6):1368-1379. PubMed ID: 31682037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of ENA gapmers as fine-tuning antisense oligonucleotides with sequence-specific inhibitory activity on mouse PADI4 mRNA expression.
    Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2006; (50):319-20. PubMed ID: 17150946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Gene Expression Knock-Down by Chemically and Structurally Modified Gapmer Antisense Oligonucleotides.
    Lisowiec-Wąchnicka J; Danielsen MB; Nader EA; Jørgensen PT; Wengel J; Pasternak A
    Chembiochem; 2022 Aug; 23(15):e202200168. PubMed ID: 35675170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.